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Recent evidence indicates that skeletal muscle influ-
ences systemic aging, but little is known about the
signaling pathways and muscle-released cytokines
(myokines) responsible for this intertissue communi-
cation. Here, we show that muscle-specific overex-
pression of the transcription factor Mnt decreases
age-related climbing defects and extends lifespan
inDrosophila.Mnt overexpression in muscle autono-
mously decreases the expression of nucleolar com-
ponents and systemically decreases rRNA levels
and the size of the nucleolus in adipocytes. This
nonautonomous control of the nucleolus, a regulator
of ribosome biogenesis and lifespan, relies on Myo-
glianin, a myokine induced by Mnt and orthologous
to human GDF11 and Myostatin. Myoglianin overex-
pression in muscle extends lifespan and decreases
nucleolar size in adipocytes by activating p38
mitogen-activated protein kinase (MAPK), whereas
Myoglianin RNAi in muscle has converse effects.
Altogether, these findings highlight a key role for
myokine signaling in the integration of signaling
events in muscle and distant tissues during aging.
INTRODUCTION
Aging is characterized by changes inmultiple organ systems that
collectively decrease the ability of the organism to withstand
homeostatic perturbations (Kenyon, 2010). Depending on the
tissue considered, tissue-specific activation of longevity path-
ways can result in only local effects (i.e., prevention of tissue
aging without systemic effects; Wessells et al., 2004) or also in-
fluence aging processes in other tissues via endocrine signals
(Durieux et al., 2011; Giannakou et al., 2004; Hwangbo et al.,
2004; Karpac et al., 2011; Libina et al., 2003; Rera et al., 2011;
Satoh et al., 2013; Taguchi et al., 2007; van Oosten-Hawle
et al., 2013; Wang et al., 2005, 2008). This network of tissue in-
teractions has been proposed to coordinate the rate of aging
of different tissues within an organism and regulate lifespanC(Panowski and Dillin, 2009; Russell and Kahn, 2007). However,
despite its importance, the key tissues and endocrine signals
involved are only in part known.
Epidemiological studies in humans indicate that the mortality
rate and pathogenesis of many age-related diseases are associ-
ated with sarcopenia and the functional status of skeletal muscle
(Metter et al., 2002; Ruiz et al., 2008; Swindell et al., 2010). These
findings suggest that the muscle is a key tissue with the capacity
to influence systemic aging and lifespan (Demontis et al., 2013a,
2013b; Nair, 2005). In line with this hypothesis, several muscle-
specific genetic interventions have been recently reported to
extend lifespan in mice and in the fruit fly Drosophila (Demontis
and Perrimon, 2010; Demontis et al., 2013a; Duteil et al., 2010;
Gates et al., 2007; Hakimi et al., 2007; Katewa et al., 2012;
Owusu-Ansah et al., 2013; Pospisilik et al., 2007). For instance,
muscle-specific overexpression of uncoupling protein 1 (UCP1)
in mice increases the median lifespan and decreases the inci-
dence of several age-related pathologies arising in nonmuscle
tissues, such as lymphomas, diabetes, and hypertension (Gates
et al., 2007). Moreover, activation of the transcription factor
FOXO and its target 4E-BP solely in skeletal muscles preserves
muscle function, extends lifespan and prevents the gradual
accumulation of polyubiquitin protein aggregates in muscles
and other aging tissues via the autonomous and nonautonomous
increase in basal autophagy in Drosophila (Demontis and Perri-
mon, 2010; Bai et al., 2013). Although these findings underscore
the fundamental role of muscles in regulating systemic aging, the
molecular mechanisms involved in this intertissue communica-
tion are largely unknown.
Over the past decade, skeletal muscle has been recognized as
an endocrine tissue with the capacity to secrete several cyto-
kines and growth factors, known as myokines, which can act
on distant tissues such as the adipose tissue, liver, pancreatic
b cells, and endothelium (Demontis et al., 2013a; Pedersen
and Febbraio, 2012). For example, activity of the transcriptional
coactivator peroxisome proliferator-activated receptor g coacti-
vator-1a (PGC-1a) in muscle protects from obesity and diabetes
in mice at least in part via the induction of irisin, a myokine that
promotes browning of white adipose tissues (Bostro¨m et al.,
2012). Whether the emerging role of skeletal muscle in influ-
encing systemic aging and lifespan depends on the action of
myokines is largely unknown.ell Reports 7, 1481–1494, June 12, 2014 ª2014 The Authors 1481
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In this study, we found that overexpression of the transcription
factor Mnt in skeletal muscle extends lifespan and regulates
nucleolar function autonomously in muscle and nonautono-
mously in adipocytes. In muscle, Mnt decreases the expression
of nucleolar components and rRNA levels and promotes the
expression of myoglianin, a secreted protein homologous to
human GDF11 and myostatin. In turn, overexpression of myo-
glianin in muscle leads to a systemic decrease in rRNA levels
and reduces nucleolar size in adipocytes by activating the
stress-sensing kinase p38 mitogen-activated protein kinase
(MAPK). Altogether, these findings indicate a key role for myo-
kine signaling in the intertissue regulation of aging.
RESULTS
Mnt Activity in Skeletal Muscle Decreases the
Expression of Nucleolar Components and Extends
Lifespan
Drosophila Mnt is a basic helix-loop-helix transcription factor
homologous to human MNT/MAD that decreases the growth
and proliferation of epithelial cells by directly regulating the
expression of several target genes involved in ribosome biogen-
esis and cellular anabolism (Hurlin and Huang, 2006; Orian et al.,
2005). AlthoughMnt null flies are short-lived (Loo et al., 2005), the
role of Mnt in aging is not understood. In Drosophila, Mnt protein
is detected in the nuclei of several tissues, including skeletal
muscle of adult flies (Figure S1). To test whether muscle-
restricted overexpression of Mnt regulates lifespan, we used
the Mhc-Gal4 driver, which has been previously shown to drive
transgene expression specifically in skeletal muscle but not in
nonmuscle tissues (Demontis and Perrimon, 2010; Schuster
et al., 1996). We crossed the skeletal-muscle-specific Mhc-
Gal4 line with either males carrying a UAS-Mnt transgene
or isogenic siblings having the same genetic background but
no transgene and analyzed the resulting progenies (Mhc-
Gal4/+ and Mhc-Gal4/UAS-Mnt). We also analyzed heterozy-
gous +/UAS-Mnt flies as additional controls.Mnt overexpressionFigure 1. Mnt Overexpression in Skeletal Muscle Extends Lifespan and
Gene Expression
(A and B)Mnt overexpression in skeletal muscle extended the median andmaxim
72.4/90 days; p < 0.0001) and reduced the percentage of flies with age-related c
siblings (Mhc-Gal/+; gray; n = 257; median/maximum lifespan = 54.8/78 days) a
n = 236; median/maximum lifespan = 55.7/80 days). RelativeMntmRNA levels ar
tailed Student’s t test.
(C) Gene expression profiling of skeletal muscle overexpressingMnt and controls
the ribosome are significantly represented among the target genes having decrea
expected count).
(D) Relative mRNA levels of nucleolar components from skeletal muscles with incr
blue) decreased the mRNA levels of nucleolar components as compared with
expression. SEM is indicated with n = 4; unpaired two-tailed Student’s t test.
(E)Mnt overexpression (blue) decreased the activity of luciferase reporters based
components) as compared with controls (YFP overexpression; gray). SEM is ind
In (D) and (E), *p < 0.05; **p < 0.01; ***p < 0.001; unpaired two-tailed Student’s t
(F and G) CG5033 RNAi in skeletal muscle extended the median lifespan (F; Mhc
p < 0.0001; log-rank test) and reduced the percentage of flies with age-related
treatment againstwhite (Mhc-Gal/UAS-whiteRNAi; black; n = 57; median/maximum
CG5033RNAi; blue dotted line; n = 90; median/maximum lifespan = 67.7/94). Relat
***p < 0.001; unpaired two-tailed Student’s t test.
See also Figures S1–S3.
Cin skeletal muscle extended both the median and maximum
lifespan (Figure 1A), and this effect was not associated with
changes in muscle mass, body weight, or feeding behavior, as
assessed with capillary feeding (CAFE) assays (Figure S2 and
data not shown). We next used negative geotaxis assays to
test whether Mnt regulates age-related muscle functional decay
and found that Mnt overexpression in muscle lowers the per-
centage of flies with climbing defects during aging (Figure 1B).
Lifespan extension and preservation of climbing ability was
also obtained by inducing Mnt overexpression with the dMef2-
Gal4 driver under control of the temperature-sensitive Gal80ts
(Figure S3).
To examine the transcriptional changes induced by Mnt in
skeletal muscle, we profiled gene expression changes with Affy-
metrix microarrays. Gene ontology cell-component terms most
significantly downregulated by Mnt overexpression included
ribosomal proteins and components of the nucleolus (Figure 1C),
a nuclear compartment necessary for ribosome subunit biogen-
esis (Dimario, 2004), suggesting that the nucleolus is a key
effector of Mnt in lifespan regulation. Quantitative RT-PCR
(qRT-PCR) confirmed a decrease in the expression of genes en-
coding nucleolar components (Nop5, Nop56, Nop60, CG4364,
and CG5033) inMnt-overexpressing muscles, whereas muscles
from Mnt/ null flies showed an increase in the expression of
these genes (Figure 1D). Luciferase assays in Drosophila S2R+
cells with reporters based on the promoters of CG4364 and
CG5033 further confirmed this regulation (Figure 1E).
The nucleolus has been linkedwith the regulation of replicative
senescence in yeast (Guarente, 1997) and is emerging as a key
cellular hub for stress sensing in multicellular organisms (Boulon
et al., 2010; Mayer et al., 2005; Michel et al., 2011). Interventions
that delay cellular aging and extend lifespan, such as rapamycin,
AMP-activated protein kinase activity, and decreased target of
rapamycin signaling, are known to reduce the size and function
of the nucleolus (Grewal et al., 2007; Hoppe et al., 2009; Iadevaia
et al., 2012; Zhang et al., 2000). On this basis, we next tested
whether the nucleolus is per se a determinant of lifespan actingDecreases Age-Related Muscle Dysfunction and Nucleolar Protein
um lifespan (A;Mhc-Gal4/UAS-Mnt; blue; n = 311; median/maximum lifespan =
limbing defects (B; p < 0.001; log-rank test) as compared with isogenic control
nd heterozygous UAS-transgene-alone controls (+/UAS-Mnt; blue dotted line;
e shown in the inset with n = 4 and SEM indicated; ***p < 0.001; unpaired two-
with Affymetrix microarrays. Genes encoding components of the nucleolus and
sed expression in response to Mnt transcriptional activity (p < 0.05; Exp Count,
easedMnt levels, fromMnt/ null flies, and controls.Mnt overexpression (dark
controls (dark gray). Conversely, Mnt loss of function (blue) led to increased
on the promoters of the CG4364 and CG5033 genes (which encode nucleolar
icated with n = 16.
test.
-Gal4/UAS-CG5033RNAi; blue; n = 152; median/maximum lifespan = 81.9/98;
climbing defects (G; p < 0.01; log-rank test) as compared with a mock RNAi
lifespan = 68.6/86) and heterozygous UAS-transgene-alone controls (+/UAS-
ive CG5033mRNA levels are shown in the inset with n = 4 and SEM indicated;
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Figure 2. Mnt Overexpression in Muscle
Systemically Regulates rRNA Levels and
Nonautonomously Reduces Nucleolar Size
in Adipocytes
(A and B) qRT-PCR analysis of rRNA levels in fly
thoraces (which consist mostly of skeletal muscle)
and heads and abdomens (which consist mostly
of nonmuscle tissues) from flies overexpressing
Mnt specifically in muscle with the Mhc-Gal4
driver. rRNA levels decline during aging in
thoraces, heads, and abdomens. Flies over-
expressing Mnt in skeletal muscle (Mhc-Gal4/
UAS-Mnt) display low levels of rRNA already in
young age in both thoraces (A) and heads and
abdomens (B) in comparison with control flies
(Mhc-Gal4/+). SEM and n are indicated with *p <
0.05, **p < 0.01, and ***p < 0.001; two-way ANOVA
followed by Tukey’s post test.
(C–F) As compared with controls (C and E), over-
expression of Mnt in skeletal muscle decreases
the nucleolar size of adipocytes already in young
age (D), anticipating the decline typically observed
in old age (E and F). The nucleolar marker fibrillarin
(red) is shown together with DAPI staining for
nuclei (green) and F-actin (phalloidin; blue). Scale
bar is 10 mm.
(G) Nucleolar size quantification is shown with
SEM and n indicated; *p < 0.05; **p < 0.01; ***p <
0.001; two-way ANOVA followed by Tukey’s
post test.
See also Figure S4.downstream of Mnt. Considering that ribosome biogenesis is
the major functional output of the nucleolus (Dimario, 2004),
we phenocopied decreased nucleolar function by knocking
down proteins required for rRNA processing and ribosome
biogenesis and function. RNAi against CG5033, Nopp140,
RpLP0, RpS3, eIF-4a, Brf, and Ssrp in muscles extended the1484 Cell Reports 7, 1481–1494, June 12, 2014 ª2014 The Authorsmedian lifespan as compared to white
RNAi and upstream activating sequence
(UAS)-RNAi alone controls (Figures 1F
and 1G; Figure S3), suggesting that a
partial reduction in nucleolar function
can delay aging.
Mnt Activity in Skeletal Muscle
Nonautonomously Decreases
Nucleolar Size in Adipocytes and
rRNA levels
Considering that Mnt decreases the
expression of several nucleolar compo-
nents (Figure 1), we next tested whether
Mnt also reduces nucleolar function. By
measuring ribosomal 28S rRNA levels,
which are indicative of the functional
status of the nucleolus, we found that
Mnt overexpression in muscle resulted
in lower 28S rRNA levels when com-
pared to controls (Figure 2A). We also
found that rRNA levels decrease duringaging, indicating that Mnt prematurely induces this decline
(Figure 2A).
Aging is characterized by the occurrence of degenerative
changes as well as by compensatory stress responses that
counteract aging itself (Haigis and Yankner, 2010). Considering
that RNAi interventions mimicking decreased nucleolar function
extend the median lifespan (Figure S3), a reduction in rRNA
levels is most likely part of a protective stress response activated
during aging and induced by Mnt.
While Mnt overexpression in muscle led to lower rRNA
levels in thoraces, which consist mostly of muscle (Figure 2A),
it also induced a similar response in heads and abdomens,
which are enriched in nonmuscle tissues (Figure 2B). The
observation that Mnt activity solely in muscle regulates rRNA
levels systemically (Figure 2B) suggests that Mnt contributes
to the intertissue communication that has been proposed to
be an important determinant of aging and lifespan in multiple
species.
On this basis, we next asked whether the Mnt-induced
systemic regulation of rRNA levels also entails cellular changes
in distant tissues. Specifically, we tested whether muscle-
restricted overexpression of Mnt regulates nucleolar size in the
adipose tissue, a key target tissue for metabolic crosstalk with
muscle in mammals and Drosophila (Demontis et al., 2013a).
The size of the nucleolus is representative of its functional status
and can be monitored with antibodies against the nucleolar
component fibrillarin/Nop1p (Boulon et al., 2010; Dimario,
2004). Consistent with a nonautonomous role for Mnt in regu-
lating the nucleolus, Mnt overexpression in skeletal muscle led
to smaller nucleoli in adipocytes of young flies (Figures 2D and
2G) as compared with controls (Figure 2C).
By comparing adipocytes from young and old control flies,
we also found that a decrease in nucleolar size is observed
during aging (Figures 2C, 2E, and 2G), and that Mnt prema-
turely induces this response (Figures 2C–2G). Conversely,
adipocytes from Mnt/ null flies, which are short-lived (Loo
et al., 2005), had larger nucleoli than controls throughout aging
(Figure S4).
Altogether, these findings indicate that Mnt activity in skeletal
muscle nonautonomously regulates nucleolar size in adipo-
cytes and that the nucleolus is dynamically regulated during
aging.
Transgenic RNAi Screening Identifies Myoglianin as a
Myokine Regulating Lifespan and Induced by Mnt
The observation that Mnt activity in muscle nonautonomously
regulates the nucleolus in adipocytes suggests a possible role
of factors released by muscles and induced by Mnt. Several
cytokines and growth factors, known as myokines, are known
to be secreted by skeletal muscle and transduce signals from
muscle to distant tissues in humans (Demontis et al., 2013a;
Pedersen and Febbraio, 2012). To identify myokines regulating
lifespan in Drosophila, we used the skeletal muscle-specific
Mhc-Gal4 driver to perform a transgenic RNAi screen with a
set of UAS-RNAi transgenes encoding known secreted proteins
(Figure 3A). No developmental or growth defects were observed
under any of the RNAi treatments, consistent with the previous
finding that the Mhc-Gal4 line used drives only minimal trans-
gene expression during skeletal muscle development (Demontis
and Perrimon, 2010). To identify lifespan regulators, the survival
of cohorts of male flies with a given RNAi treatment in muscle
wasmonitored during aging and compared to a control syngenic
RNAi treatment againstwhite (Figure 3A). RNAi knockdowns that
decreased the median lifespan included 2 independent RNAiClines against myoglianin (Figures 3B and S5), which also
increased the percentage of flies with climbing defects in old
age as compared to controls (Figures 3C and S5). Myoglianin
is a secreted transforming growth factor b (TGF-b) ligand ex-
pressed primarily in glial cells and skeletal muscle in Drosophila
(Awasaki et al., 2011; Lo and Frasch, 1999; Serpe and O’Connor,
2006) and orthologous to human Myostatin/Growth Differentia-
tion Factor-8 (GDF8) and the related factor GDF11 (Figure 3D).
In mammals, Myostatin inhibits muscle growth and regeneration
(Lee, 2004; McPherron et al., 1997; Sartori et al., 2013), but
neither Myostatin nor GDF11 has been implicated in lifespan
determination.
Given the high degree of sequence conservation of this myo-
kine across species and its role in lifespan determination in
Drosophila (Figure 3), we next tested whether Myoglianin is a
myokine regulated byMnt. As indicated by qRT-PCR,myoglianin
expression increased in skeletal muscle overexpressing Mnt,
whereas muscle from Mnt/ null flies had lower myoglianin
mRNA levels (Figure 3E). To further confirm the role of Mnt in
regulating myoglianin expression, we generated luciferase tran-
scriptional reporters based on the myoglianin gene promoter. In
agreement with in vivo findings (Figure 3E), Mnt overexpression
in Drosophila S2R+ cells resulted in highermyoglianin-luciferase
reporter activity than yellow fluorescent protein (YFP) overex-
pression (Figure 3F). Taken together, these results indicate that
the Drosophila Myostatin/GDF11 ortholog Myoglianin is a myo-
kine that is induced by Mnt.
Mnt/Myoglianin Signaling Regulates Lifespan
We next asked whether myoglianin overexpression regulates
lifespan. Similar to Mnt (Figure 1), myoglianin overexpression in
muscle extended both the median and maximum lifespan (Fig-
ure 4A) and resulted in a lower percentage of flies with climbing
defects during aging (Figure 4B) as compared with isogenic con-
trols. Lifespan extension and preservation of climbing ability was
also obtained by overexpressing myoglianin in adulthood with
dMef2-Gal4 under the temporal control of Gal80ts (Figure S3).
Opposite tomyoglianin overexpression, RNAi againstmyoglianin
shortened the median lifespan (Figure 4C) and resulted in a
higher percentage of age-related climbing defects (Figure 4D)
as compared to RNAi against white. Notably, heterozygous
UAS-transgene alone controls did not cause changes in lifespan
and climbing without the Mhc-Gal4 driver (Figures 4A–4D). In
addition, no significant changes in muscle mass, body weight,
and feeding behavior were observed upon myoglianin overex-
pression and RNAi with the Mhc-Gal4 driver (Figure S2 and
data not shown).
Considering thatMnt regulatesmyoglianin levels (Figure 3) and
that both Mnt and Myoglianin extend lifespan (Figures 1 and 4),
we next asked whether Myoglianin contributes to the lifespan
extension that follows Mnt activation in muscles. To this end, a
recombined line carrying the Mhc-Gal4 and UAS-Mnt trans-
genes was crossed with RNAi lines targeting either myoglianin
or white (control). A decrease in myoglianin mRNA levels
reduced the lifespan extension and preservation of muscle func-
tion associated with Mnt overexpression (Figures 4E, 4F, and
S6), indicating that Myoglianin contributes in part to the prolon-
gevity effects of Mnt.ell Reports 7, 1481–1494, June 12, 2014 ª2014 The Authors 1485
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Muscle-Derived Myoglianin Regulates rRNA Levels
Organism-wide
In mammals, both Myostatin and GDF11 are detected in the cir-
culation (Souza et al., 2008; Zimmers et al., 2002), from where
they have been proposed to act on nonmuscle cells (McPherron,
2010). Considering that Myoglianin acts downstream of Mnt in
regulating lifespan (Figures 3 and 4), we asked whether mus-
cle-derivedMyoglianin regulates rRNA levels in muscle and non-
muscle tissues as observed following Mnt overexpression in
muscle. In agreement with this scenario, rRNA levels decreased
in young age in thoraces (Figure 5A) and heads and abdomens
(Figure 5B) in response to myoglianin overexpression in muscle,
anticipating the age-related decline in rRNA levels observed in
control flies (Figures 5A and 5B).
We next asked whethermyoglianin knockdown in muscle also
elicits systemic effects. Opposite to its overexpression,myoglia-
nin RNAi in muscle led to higher rRNA levels in old age in both
thoraces and heads and abdomens, partially preventing the
decline in rRNA levels observed during aging (Figures 5C and
5D). Taken together, these findings indicate that Myoglianin reg-
ulates rRNA levels in the whole organism during aging.
Muscle-Derived Myoglianin Regulates Nucleolar Size in
Adipocytes via p38 MAPK
Given the role of Myoglianin in regulating rRNA levels, we next
tested whether muscle-derived Myoglianin regulates nucleolar
size in adipocytes. To this purpose, myoglianin was overex-
pressed specifically in skeletal muscle with the Mhc-Gal4
line. As compared with controls (Figures 6A, 6B, and 6I), myo-
glianin overexpression in muscle led to smaller nucleoli in
adipocytes (Figures 6C and 6D). Conversely, RNAi-mediated
knockdown of myoglianin specifically in muscle led to
increased nucleolar size in adipocytes throughout aging (Fig-
ures 6G and 6H) as compared to RNAi against white (Figures
6E, 6F, and 6J). Altogether, these findings indicate that Myo-
glianin is a myokine that regulates nucleolar size in adipocytes
during aging.Figure 3. Muscle-Restricted RNAi Screening Identifies Myoglianin, a M
(A) Scheme of the RNAi screen for myokines regulating lifespan and age-related m
Mhc-Gal4 driver (specific for skeletal muscles) were crossed with males from a
genetic background, to knock down a given cytokine or growth factor specifica
muscular function) was measured in young (day 8, yellow arrow) and older (day 36
(the day at which 50% of flies are alive; blue arrow) and the maximum lifespan (t
(B) RNAi screen results ordered by ascending median lifespan. Each blue dot r
typically 60 flies with a muscle-specific RNAi intervention (TRiP RNAi ID is shown
represent the maximum lifespan of the same cohort. Two different RNAi treatmen
red) shortened the median lifespan as compared with a control RNAi against wh
extended lifespan (Figure S5).
(C) The percentage of flies with climbing defects at day 8 (yellow), 36 (orange), an
increased the percentage of flies with climbing defects in old age as comparedwith
climbing defects in young age (day 8), indicating that the differences observed in o
Procedures and Figure S5 for statistical analysis of the screen.
(D) Phylogenetic analysis of Drosophila BMP and TGF-b ligands shows that Myog
Myostatin (GDF8) and GDF11. Alignment of the mature DrosophilaMyoglianin an
(47%; *) and similarities (69%; :).
(E) Mnt overexpression in skeletal muscles significantly increased myoglianin ex
levels. SEM is indicated with n = 4; *p < 0.05; unpaired two-tailed Student’s t tes
(F) Overexpression ofMnt (blue) in Drosophila S2R+ cells resulted in highermyogl
is indicated with n = 16; ***p < 0.001; unpaired two-tailed Student’s t test.
CMyostatin and GDF11 can signal via the activation of several
intracellular effectors in mammals (Lee, 2004). We therefore
sought to determine the Myoglianin signal transducers that
regulate nucleolar function in this context. In response to Mnt/
Myoglianin signaling, we detected substantial changes in the
phosphorylation and hence activity of the stress-sensing kinase
p38 MAPK (Figure 7A), a known transducer of Myostatin and
TGF-b signaling in mammals (Li et al., 2008; Moustakas and Hel-
din, 2005; Philip et al., 2005). Interestingly, p38 MAPK protects
from age-dependent motor deficits and extends lifespan in mul-
tiple species (Vrailas-Mortimer et al., 2011; Youngman et al.,
2011), suggesting that it may play an important role downstream
of Mnt/Myoglianin signaling. Increased phospho-p38 MAPK
levels were detected in both thoracic fractions (consisting of
transgene expressing muscles) and head and abdominal frac-
tions (enriched in nonmuscle tissues with no transgene expres-
sion) from young and old flies with either Mnt or myoglianin
overexpression in muscles in comparison to controls (Figure 7A).
Conversely,myoglianin knockdown in muscles led to a decline in
phospho-p38 MAPK levels in both muscle and nonmuscle tis-
sues compared with mock RNAi treatments against white (Fig-
ure 7A). Similar changes in phospho-p38 MAPK levels were
observed in muscle overexpressing Mnt and having myoglianin
knockdown (Figure S7). There were no changes in phospho-
p38 MAPK in UAS-alone controls in the absence of Gal4-driven
transgene expression (Figure S7). Moreover, total p38 levels did
not change in response to Mnt and myoglianin overexpression
and RNAi, indicating that Mnt andMyoglianin regulate p38 activ-
ity rather than total p38 protein levels (Figure S7). In addition, no
changes in phospho-p70 S6K levels were detected (Figure S7).
Taken together, these findings suggest that Mnt activity in
muscles and Myoglianin levels are sensed systemically via p38
MAPK phosphorylation and activation in target tissues.
To investigate whether p38 MAPK regulates nucleolar size
in adipocytes, we overexpressed wild-type (WT) or dominant-
negative (kinase-dead [KD]) p38 MAPK in adipocytes with
ppl-Gal4. Increased levels of p38 WT led to smaller nucleoliyokine Regulating Lifespan and Induced by Mnt
uscle dysfunction in the fruit flyDrosophila melanogaster. Females carrying the
collection of Gal4-responsive UAS-RNAi transgenes, generated in a similar
lly in the skeletal muscle of the progeny. Climbing ability (indicative of neuro-
, orange arrow; and day 56, red arrow) ages, together with the median lifespan
he day at which the last fly in a cohort is alive; gray arrow).
epresents the median lifespan (indicated in days on the y axis) of a cohort of
on the x axis of the graph in C, see also Figure S5). Corresponding gray dots
ts in skeletal muscles against the TGF-b ligandmyoglianin (arrow and name in
ite (arrow and name in blue). RNAi in muscle for several Insulin-like peptides
d 56 (red) for the cohorts of flies with lifespan reported in (B).Myoglianin RNAi
a control RNAi againstwhite. Note that none of the RNAi treatments resulted in
lder age are not due to developmental defects. See Supplemental Experimental
lianin is the sole Drosophila homolog of the highly related human TGF-b ligands
d human GDF11 and Myostatin peptides shows extensive sequence identities
pression, whereas muscles from Mnt/ null flies had lower myoglianin mRNA
t.
ianin-luciferase reporter activity than controls (YFP overexpression; gray). SEM
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Figure 4. Mnt/Myoglianin Signaling Regu-
lates Lifespan and Muscle Function during
Aging
(A and B) Myoglianin overexpression (Mhc-
Gal4/UAS-myoglianin; green; n = 458; median/
maximum lifespan = 75.5/94 days) in skeletal
muscles extended the median and maximum
lifespan (A; p < 0.0001; log-rank test) and reduced
the percentage of flies with age-related climbing
defects (B; p < 0.01; log-rank test) as com-
pared with isogenic control siblings (MhcGal4/+;
gray; n = 152; median/maximum lifespan =
59.3/78 days) and heterozygous UAS-transgene-
alone controls (UAS-myoglianin/+; green dotted
line; n = 370; median/maximum lifespan = 53/
86 days).
(C) Muscle-specific knockdown of myoglianin
(RNAi#1: red; n = 275; median/maximum life-
span = 55.9/88 days; RNAi#2: orange; n = 731;
median/maximum lifespan = 59.1/86 days) short-
ened the median lifespan (p < 0.0001; log-rank
test) as compared with white knockdown
(gray, control; n = 290; median/maximum life-
span = 69.5/96 days) and heterozygous flies
carrying UAS-RNAi transgenes alone (UAS-
myoglianinRNA#1/+: red dotted line, n = 367;
median/maximum lifespan = 67.2/92 days; UAS-
myoglianinRNAi#2/+: orange dotted line, n = 323;
median/maximum lifespan = 67.1/92; and UAS-
whiteRNAi/+: gray dotted line, n = 307; median/
maximum lifespan = 69.6/88).
(D) The percentage of flies with climbing
defects progressively increased during aging in
controls but to a greater extent in flies with
myoglianin knockdown in muscles (p < 0.01; log-
rank test).
(E) Myoglianin knockdown (RNAi#1: pink, n =
142; median/maximum lifespan = 66.5/88 days;
and RNAi#2: violet, n = 192; median/maximum
lifespan = 66.6/88 days) reduced the life-
span extension resulting from Mnt over-
expression in muscles (p < 0.001; log-rank
test) as compared with control white knock-
downs (RNAi#1: gray, n = 140; median/
maximum lifespan = 78.2/100 days; and RNAi#2,
black, n = 179; median/maximum lifespan =
82.4/104).
(F) A higher percentage of flies with climbing defects was observed during aging when myoglianin levels were reduced in skeletal muscles overexpressing Mnt
(p < 0.01; Log-rank test).
In all panels, relative myoglianin mRNA levels are shown in insets with n = 4 and SEM indicated; *p < 0.05, **p < 0.01, and ***p < 0.001; unpaired two-tailed
Student’s t test.
See also Figures S3 and S6.(Figures 7B, 7C, and 7H) than those in controls (Figures 7D, 7E,
and 7H). Conversely, p38 KD overexpression led to increased
nucleolar size throughout aging (Figures 7F–7H), even when
myoglianin was concomitantly overexpressed (Figure 7I), indi-
cating that p38 MAPK activity is a key regulator of nucleolar
size in adipocytes downstream of Myoglianin.
DISCUSSION
In multicellular organisms, crosstalk between tissues and or-
gans is responsible for the homeostatic regulation of many
physiological functions. Recent evidence suggests that intertis-1488 Cell Reports 7, 1481–1494, June 12, 2014 ª2014 The Authorssue signaling is also an important determinant of systemic ag-
ing and lifespan (Panowski and Dillin, 2009; Russell and Kahn,
2007). However, the key tissues, signaling pathways, and
endocrine factors involved in this long-distance communication
are only in part known. In this study, we have identified an in-
tertissue myokine-based longevity pathway that mediates the
crosstalk between skeletal muscle and adipose tissue during
aging via the transcription factor Mnt and the myokine Myoglia-
nin (Figure 7J). The activity of the transcription factor Mnt in
skeletal muscles leads to both local and systemic responses
that delay whole-organism aging. Cell autonomously, Mnt
reduces the function of the nucleolus by decreasing the
Figure 5. Muscle-DerivedMyoglianin Regu-
lates Nucleolar Function during Aging
qRT-PCR analysis of rRNA levels in fly thoraces
(which consist mostly of skeletal muscle) and
heads and abdomens (which consist mostly of
nonmuscle tissues) from flies expressing different
levels of myoglianin in skeletal muscle.
(A and B) rRNA levels decline during aging in
thoraces, heads, and abdomens. Flies over-
expressing myoglianin in skeletal muscle (Mhc-
Gal4/UAS-myoglianin) display low levels of rRNA
already in young age in both thoraces and heads
and abdomens in comparison with control flies
(Mhc-Gal4/+).
(C and D) rRNA levels do not decline during aging
in thoraces, heads, and abdomens from flies with
myoglianinRNAi in skeletal muscle (Mhc-Gal4/
UAS-myoglianinRNAi) in comparison with control
flies (Mhc-Gal4/UAS-whiteRNAi).
In all panels, n = 4 and SEM is indicated; *p < 0.05,
**p < 0.01, and ***p < 0.001; two-way ANOVA
followed by Tukey’s post test.expression of nucleolar genes and rRNA levels in muscle. In
addition, Mnt increases the expression of myoglianin in muscle
and this myokine has both local and systemic effects. In mus-
cle, Myoglianin reduces rRNA levels and age-related muscle
dysfunction. Systemically, muscle-restricted myoglianin over-
expression leads to lower rRNA levels and reduces nucleolar
size in adipocytes by modulating the activity of the stress-
sensing kinase p38 MAPK. Direct binding of Myoglianin to its
cellular receptor and activation of TAK1 (TGF-b-activated ki-
nase 1) may be responsible for the regulation of p38 MAPK ac-
tivity in muscle and the adipose tissue, as previously observed
in mammals (Li et al., 2008; Moustakas and Heldin, 2005; Philip
et al., 2005).
We fond that a prominent cellular response induced by Mnt/
Myoglianin/p38 MAPK signaling is the regulation of nucleolar
function. The nucleolus is a key promoter of cellular anabolism
(Dimario, 2004), and its activity is reduced in response to several
genetic and pharmacological interventions that are known to
extend lifespan (Grewal et al., 2007; Hoppe et al., 2009; Iade-
vaia et al., 2012; Zhang et al., 2000). In line with the notion
that a moderate reduction in cellular anabolism and protein
translation delays aging (Hansen et al., 2007; Kenyon, 2010;
Pan et al., 2007; Steffen et al., 2008; Syntichaki et al., 2007),
we have found that decreasing nucleolar function is a protective
response induced to counteract aging and sufficient to extend
lifespan.
The coordinated regulation of the nucleolus across aging
tissues via Myoglianin may represent an assurance mechanism
to delay tissue aging systemically and to robustly extend life-
span in response to localized activity of the transcription factor
Mnt in muscle. Considering that skeletal muscle constitutes theCell Reports 7, 1481–149major reservoir of proteins in the organ-
ism (Wolfe, 2006) and that it has high
levels of ribosome biogenesis (Drum-
mond et al., 2009), which occurs in the
nucleolus, sensing and regulating thefunctional status of the nucleolus in this tissue may be of partic-
ular relevance for coordinating the aging of different tissues and
determining lifespan.
The Myoglianin orthologs Myostatin and GDF11 may regulate
lifespan and have similar endocrine roles in humans since they
are circulating factors detected in the bloodstream (Souza
et al., 2008; Zimmers et al., 2002) and may act on several target
tissues, including adipocytes (Feldman et al., 2006; McPherron,
2010). In agreement with this scenario, GDF11 has been recently
shown to act systemically to delay heart aging in mice (Loffredo
et al., 2013). Future studies in mice shall test whether GDF11 ex-
erts this function via the modulation of p38 MAPK and the
nucleolus.
In addition to systemic effects, we found that Mnt and Myo-
glianin have cell-autonomous/autocrine effects in preserving
muscle function during aging. Specifically, overexpression of
Mnt and myoglianin in muscle preserves the flies’ climbing abil-
ity during aging, whereasmyoglianin RNAi has converse effects.
Considering that there are no changes in muscle mass in the
adult Drosophila (Piccirillo et al., 2014) and in response to
Mnt/Myoglianin signaling in adult flies (Figure S2), the preven-
tion of age-related motor dysfunction by Mnt/Myoglianin
signaling in this context does not entail changes in muscle
mass but rather derives at least in part from the activation in
preexisting myofibers of p38 MAPK, which is known to prevent
age-related muscle functional decline in Drosophila (Vrailas-
Mortimer et al., 2011). In line with these findings, Myostatin
knockout mice have decreased force generation when normal-
ized to the cross-sectional area of the muscle (specific force)
and may thus experience proportionally higher myofiber func-
tional decay during aging than control mice, although they4, June 12, 2014 ª2014 The Authors 1489
Figure 6. Muscle-Derived Myoglianin Regulates Nucleolar Size in Adipocytes
(A–H) Immunostaining of adipose tissue for the nucleolus (fibrillarin; red), F-actin (phalloidin; blue), and nuclei (DAPI; green). (C and D) Overexpression of
myoglianin in skeletal muscles decreased the nucleolar size of adipocytes already in young age as comparedwith controls (A), anticipating the decline in nucleolar
size typically observed in old age (B). (G and H) Muscle-restricted myoglianin RNAi increased nucleolar size in adipocytes in young and old age, in comparison
with a control RNAi against white (E and F). Scale bar is 10 mm.
(I and J) Nucleolar size quantification is shown with SEM and n indicated; **p < 0.01; ***p < 0.001; two-way ANOVA followed by Tukey’s post test.have a higher muscle mass than controls (Amthor et al., 2007;
Gentry et al., 2011).
Altogether, this study highlights a key role for myokine
signaling in lifespan regulation and in the integration of signaling1490 Cell Reports 7, 1481–1494, June 12, 2014 ª2014 The Authorsevents in different tissues during aging. Therapeutic interven-
tions aimed at modulating myokine levels and their systemic
signaling may extend healthy lifespan by simultaneously delay-
ing age-related changes in muscle and other aging tissues.
(legend on next page)
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EXPERIMENTAL PROCEDURES
Lifespan Analysis
For survival analysis, male flies were collected within 24 hr from eclosion and
reared at standard density (20 per vial) on cornmeal/soy flour/yeast fly food at
25C and 60% humidity. Dead flies were counted every 2 days and the food
was changed. The median lifespan was calculated by interpolation and corre-
sponds to the day at which 50% of the flies in a cohort are alive. The maximum
lifespan is the day at which the last fly in a cohort dies. To rule out any variation
due to cytoplasmic background effects, all crosses were set up with female
virgins from the w1118;Mhc-Gal4. To avoid any contribution of genetic back-
ground mutations to the observed lifespan phenotypes, UAS-Mnt and UAS-
myoglianin transgenes were backcrossed through more than six generations
against y1w1118 to obtain isogenic male siblings carrying either a UAS- or no
transgene (distinguished by eye color: white+ and white, respectively).
Male siblings carrying either a UAS- or no transgene and having the same
genetic background were then crossed to homozygous w1118;Mhc-Gal4
(rosy+ white) females and the resulting male progenies were sorted (based
on eye color) into isogenic transgene-expressing and transgene-nonexpress-
ing cohorts before lifespan analysis.UAS- transgene expression obtained with
Mhc-Gal4 was confirmed by qRT-PCR from fly thoraces, which consist mostly
of skeletal muscle. Heterozygous UAS- transgene-alone controls were also
analyzed to exclude that the observed phenotypes are due to differences in
the genetic background. These flies were obtained by crossing UAS- males
with female w1118 virgins isogenic to the w1118;Mhc-Gal4 stock. All the proge-
nies analyzed consisted of males. Transgenic RNAi lines used for the screen
and for lifespan studies were generated in a y1v1 background (Ni et al., 2011)
and were crossed with female virgins from the w1118 and the w1118;Mhc-
Gal4 isogenic stocks. RNAi against white was used as control to account for
any aspecific effects deriving from the engagement of the RNAi machinery.
RNAi-mediated knockdown in muscle was confirmed by qRT-PCR from fly
thoraces. Heterozygous UAS-RNAi transgene-alone controls were also
analyzed and obtained as described above. Note that the RNAi lines are on
a genetic background that is different from the y1w1118 (yellow white) genetic
background of UAS-Mnt and UAS-myoglianin lines. All the experiments
were done with males.
Climbing Assays
Negative geotaxis assays were performed as previously described (Rhoden-
izer et al., 2008). In brief, flies were gently tapped to the bottom of a plastic
vial, and the number of flies that could climb to the top of the vial after 20 s
was scored.Figure 7. Mnt Activity in Muscle Remotely Activates p38 MAPK via My
(A) Western blot analysis of fractions from either thoraces (consisting mainly of mu
tissues; lower panels) from controls and flies overexpressingMnt andmyoglianin
skeletal muscles from young (1 week) and old (8 weeks) flies. Mnt andMyoglianin i
tissues as compared with controls (left), whereas myoglianin knockdown had c
normalized to a-tubulin is indicated. See also Figure S7.
(B–H) Adipocytes labeledwith the nucleolar marker fibrillarin (red), phalloidin (F-ac
MAPK overexpression in adipocytes with the ppl-Gal4 driver led to significantly
nucleolar size which is otherwise normally observed in old age (C, E, and H). Con
overexpression of dominant-negative, kinase-dead (KD) p38 MAPK.
(I) Similar results were obtained also whenmyoglianinwas concomitantly overexp
with overexpression of a UAS-myoglianin transgene together with an empty UA
titration effects in the different genotypes analyzed (ppl-Gal4/UAS-; UAS-myogli
Statistical analysis was donewith two-way ANOVA followed by Tukey’s post test in
significant.
(J) Summary scheme.Muscle-specific overexpression ofMnt extends lifespan and
(orange), the transcription factor Mnt reduces rRNA levels and the expression of c
expression of the TGF-b ligand myoglianin, the Drosophila ortholog of human M
extends lifespan and reduces rRNA levels in the whole organism and nucleolar siz
signaling, whilemyoglianin RNAi in muscle has converse effects. In addition to ind
levels in muscle and preserves muscle function during aging. These findings high
lifespan via muscle-derived secreted proteins, i.e., myokines. Myokine-based
assurance mechanism for robust lifespan determination in aging organisms.
1492 Cell Reports 7, 1481–1494, June 12, 2014 ª2014 The AuthorsWhole-Mount Immunostaining
Whole-mount immunostaining of Drosophila adipose tissues (peripheral fat
body of the abdomen) was done as described previously (Demontis and Per-
rimon, 2010; Hunt and Demontis, 2013).
qRT-PCR and Microarray Gene Expression Profiling
Total RNA was extracted with the TRIzol reagent (Life Technologies) from at
least 15 thoraces from male flies per group, followed by cleanup with the
RNeasy kit (QIAGEN) and on-column DNase digestion. Total RNA was
reverse transcribed with the iScript cDNA synthesis kit (Bio-Rad). qRT-
PCR was performed with the iQ SYBR Green Supermix and a CFX96 Real-
Time PCR Detection System (Bio-Rad). Alpha-Tubulin 84B was used as a
normalization reference. A primer pair for the 28S rRNA was used to mea-
sure rRNA levels. Relative quantitation of mRNA levels was determined
with the comparative CT method. For microarray analysis, RNA integrity
was assessed with an Agilent 2100 Bioanalyzer before cRNA synthesis
and hybridization to Affymetrix Drosophila Genome 2.0 Arrays. Samples
from three independent biological replicates per genotype were collected
and analyzed.
Luciferase Assay
Luciferase assays were done as before (Demontis and Perrimon, 2009, 2010).
See Supplemental Experimental Procedures for detailed information and a list
of DNA plasmids used.
ACCESSION NUMBERS
Gene expression profiling data have been deposited in the NCBI Gene Expres-
sion Omnibus and are available under accession number GSE39877.
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and seven figures and can be found with this article online at http://dx.doi.
org/10.1016/j.celrep.2014.05.001.
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scles; upper panels) or heads and abdomens (consisting mainly of nonmuscle
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prevents age-relatedmuscle functional decay. In the nuclei (gray) of myofibers
omponents of the nucleolus, a regulator of aging. In addition, Mnt increases the
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